CVS HEALTH CORPORATION Finance Lease, Right-of-Use Asset, after Accumulated Amortization
CVS HEALTH CORPORATION (CVS) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $1.09 billion as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-02-10
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.09B.
- 2024-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.14B.
- 2023-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.23B.
- 2022-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.32B.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2025-12-31 | $1.09B 10-K · filed 2026-02-10 |
| 2024-12-31 | $1.14B 10-K · filed 2026-02-10 |
| 2023-12-31 | $1.23B 10-K · filed 2025-02-12 |
| 2022-12-31 | $1.32B 10-K · filed 2024-02-07 |
| 2019-09-30 | $560.00M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $531.00M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $509.00M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |